TP53 and acute myeloid leukemia: The findings of our investigation furnish substantiation to propose that VS‐5584 manifests a repressive influence on the PI3K/mTOR pathway, concomitantly stimulating the P53 pathway, thereby influencing the proliferation of AML cells.